TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Double Bond Pharmaceutical International AB (publ)
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
1,370
|
1,243
|
956 |
Financial expenses |
3,902
|
0
|
1 |
Earnings before taxes |
-17,338
|
-15,160
|
-9,257 |
EBITDA |
-13,243
|
-14,968
|
-9,085 |
Total assets |
11,597
|
15,390
|
27,797 |
Current assets |
5,018
|
6,497
|
18,712 |
Current liabilities |
6,242
|
3,319
|
3,902 |
Equity capital |
5,355
|
12,071
|
23,895 |
- share capital |
4,768
|
3,163
|
2,764 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
46.2%
|
78.4%
|
86.0% |
Turnover per employee |
137
|
124
|
96 |
Profit as a percentage of turnover |
-1265.5%
|
-1219.6%
|
-968.3% |
Return on assets (ROA) |
-115.9%
|
-98.5%
|
-33.3% |
Current ratio |
80.4%
|
195.8%
|
479.5% |
Return on equity (ROE) |
-323.8%
|
-125.6%
|
-38.7% |
Change turnover |
127
|
287
|
-204 |
Change turnover % |
10%
|
30%
|
-18% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.